Are Robust Financials Driving The Recent Rally In Ipsos SA's (EPA:IPS) Stock?

July 20, 2022
  •  Updated
September 29, 2022
ENXTPA:IPS
Source: Shutterstock

Ipsos' (EPA:IPS) stock is up by a considerable 6.3% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be paying attention to Ipsos' ROE today.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

Check out our latest analysis for Ipsos

How To Calculate Return On Equity?

The formula for return on equity is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Ipsos is:

14% = €187m ÷ €1.3b (Based on the trailing twelve months to December 2021).

The 'return' is the income the business earned over the last year. So, this means that for every €1 of its shareholder's investments, the company generates a profit of €0.14.

Why Is ROE Important For Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.

Ipsos' Earnings Growth And 14% ROE

At first glance, Ipsos seems to have a decent ROE. And on comparing with the industry, we found that the the average industry ROE is similar at 13%. This probably goes some way in explaining Ipsos' moderate 8.3% growth over the past five years amongst other factors.

Next, on comparing with the industry net income growth, we found that Ipsos' growth is quite high when compared to the industry average growth of 4.6% in the same period, which is great to see.

past-earnings-growth
ENXTPA:IPS Past Earnings Growth July 20th 2022

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. If you're wondering about Ipsos''s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Ipsos Using Its Retained Earnings Effectively?

Ipsos has a healthy combination of a moderate three-year median payout ratio of 27% (or a retention ratio of 73%) and a respectable amount of growth in earnings as we saw above, meaning that the company has been making efficient use of its profits.

Besides, Ipsos has been paying dividends for at least ten years or more. This shows that the company is committed to sharing profits with its shareholders. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 28% of its profits over the next three years. Accordingly, forecasts suggest that Ipsos' future ROE will be 13% which is again, similar to the current ROE.

Conclusion

Overall, we are quite pleased with Ipsos' performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings are expected to accelerate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

Valuation is complex, but we're helping make it simple.

Find out whether Ipsos is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis